Home > Boards > Free Zone > All Trading - Technical > Market Direction and Stock Trends

Tuesday's Top Analyst Upgrades and Downgrades: Amgen, Cirrus

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DiscoverGold Member Profile
Member Level 
Followed By 577
Posts 80,306
Boards Moderated 45
Alias Born 03/10/04
160x600 placeholder
Top Company News of the Day
The FDA's authorization expands the drug's use to fight Covid-19 to people under the age of 12.
Soybeans Futures Higher on Export Hopes - Daily Grain Highlights
FDA Expands Emergency Use for Lilly Antibody Combination for Covid-19 to Include Infants
Front Month Nymex Natural Gas Fell 24.56% This Week to Settle at $4.1320 -- Data Talk
Front Month Nymex RBOB Gasoline Fell 1.42% This Week to Settle at $1.9529 -- Data Talk
Merck in Supply Agreement With Canada for Antiviral Medicine for Covid-19
Trade Deficit, Consumer Prices on Deck -- Data Week Ahead
Sportsman's Warehouse Shares Fall 19% After Takeover Deal Terminated
EURO STOXX 50 Index Ends the Week 0.23% Lower at 4080.15 -- Data Talk
FTSE 100 Index Ends the Week 1.11% Higher at 7122.32 -- Data Talk
DAX Ends the Week 0.57% Lower at 15169.98 -- Data Talk
CAC 40 Index Ends the Week 0.38% Higher at 6765.52 -- Data Talk
STOXX Europe 50 Index Ends the Week 0.20% Higher at 3613.81 -- Data Talk
STOXX Europe 600 Index Ends the Week 0.28% Lower at 462.77 -- Data Talk
FTSE Closes Down Amid Persistent Growth Fears
Roche to Name New Member to Board of Directors, Re-Elect Chairman
Adobe Down Over 6%, On Pace for Largest Percent Decrease Since March 2020 -- Data Talk
U.S. Services Sector Growth Accelerated to New Record-High in November -- ISM
U.S. Services Sector Growth Cooled Slightly in November -- IHS Markit
FTSE Edges Higher, Wickes's Margin Outperformance Leads to Further Upgrades
U.S. Nonfarm Payrolls Up 210K in November, Unemployment Rate 4.2% -- Update
Johnson & Johnson's Janssen Says Psoriatic Arthritis Trial Meets Objective
Bostic Wants to Speed Up Fed's Asset Buying Taper; Quarles Says Fed Will Need to Raise Rates
U.S. Nonfarm Payrolls Up 210K in November, Unemployment Rate 4.2%
Bristol Myers Squibb Gets FDA Acceptance of sBLA for Reblozyl
FTSE Edges Higher, Service Sector Kept Growth Momentum in November
DiscoverGold Member Level  Tuesday, 09/07/21 09:25:45 AM
Re: None
Post # of 40438 
Tuesday's Top Analyst Upgrades and Downgrades: Amgen, Cirrus Logic, Johnson & Johnson, Lam Research, Merck, Spotify and Vertex Pharma
By: 24/7 Wall St. | September 7, 2021

These are the top analyst upgrades, downgrades and initiations seen on Tuesday, September 7, 2021.

Amgen Inc. (NASDAQ: AMGN): Morgan Stanley downgraded the stock to Equal Weight from Overweight and cut the price target to $251 from $280. Shares last closed at $226.37, and the consensus price target is $252.96.

Azure Power Global Ltd. (NYSE: AZRE): HSBC Securities upgraded it to Buy from Hold and has a $27.50 price target. The shares have a $42.25 consensus target, and Friday’s close was at $21.77.

Bank of Montreal (NYSE: BMO): The Barclays upgrade was to Equal Weight from Underweight. That compares with an $85.95 consensus target and Friday’s close at $101.97.

Cirrus Logic Inc. (NASDAQ: CRUS): Barclays upgraded it to Overweight from Equal Weight and raised the price target to $100 from $95. Shares last closed at $83.62, and the consensus price target is $105.42.

Hain Celestial Group Inc. (NASDAQ: HAIN): This is the Zacks Bear of the Day. The analyst points out that an earnings miss started a string of negative earnings estimate revisions for this stock. Shares closed most recently at $37.28 apiece and have a consensus price target of $44.91.

Johnson & Johnson (NYSE: JNJ): Morgan Stanley lowered its Overweight rating to Equal Weight with a $187 price target. The $189.61 consensus target is above Friday’s close at $175.04.

Lam Research Corp. (NASDAQ: LRCX): Exane BNP Paribas lowered its Outperform rating to Neutral with a $640 price target. Shares most recently closed at $610.71 and have a consensus price target of 742.52.

Marathon Petroleum Corp. (NYSE: MPC): Morgan Stanley initiated coverage with an Overweight rating and a $75 price target. Shares last closed at $58.24, and the consensus target price is $69.43.

McAfee Corp. (NASDAQ: MCFE): UBS downgraded it to Neutral from Buy but raised the price target to $29 from $27. The shares last closed at $27.72, and the consensus price target is $29.43.

Merck & Co. Inc. (NYSE: MRK): Morgan Stanley’s downgrade to Equal Weight from Overweight came with an $85 price target. Shares last closed at $77.26, but they have traded as high as $82.35 in the past year.

Overstock.com Inc. (NASDAQ: OSTK): BofA Securities resumed coverage with a Buy rating and an $89 price target. Shares closed most recently at $69.51 apiece and have a consensus price target of $124.50.

Phillips 66 (NYSE: PSX): Morgan Stanley started coverage with an Equal Weight rating and an $80 price target. The shares most recently closed at $69.62 and have a consensus price target of $91.36.

ScanSource Inc. (NASDAQ: SCSC): Zacks named this as its Bull of the Day stock. The analyst says that that earnings growth has been the key to this stock’s meteoric rise. Shares last closed at $37.56, and the consensus price target is $39.33.

Spotify Technology S.A. (NYSE: SPOT): KeyBanc Capital Markets lifted its Sector Weight rating to Overweight and has a $340 price target. Shares last closed at $249.04, and the consensus price target is $261.59.

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX): Morgan Stanley downgraded it to Underweight from Equal Weight and has a $202 price target. The shares most recently closed at $198.05 and have a consensus price target of $260.00.

Read Full Story »»»

DiscoverGold

Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences